Tags: industry interactions
Today Massachusetts Eye and Ear (MEE) is taking its first steps toward becoming a member of Partners HealthCare.
Under the proposed terms, MEE will keep its name and hospital license, and will remain a not-for-profit charitable health care organization. The specialty hospital will have its own board of directors, executive leadership team, medical and research staff, and direct its own community outreach and fundraising activities.
“As we look to advance patient care, research and teaching in a rapidly changing health care environment, we believe the best strategic solution for Mass. Eye and Ear is to join an integrated health care system,” said John Fernandez, President & CEO of MEE. “Given our long history of clinical and research collaboration with Partners hospitals, this feels like a clear choice.”
Founded in Boston in 1824, MEE is the oldest eye and ear, nose and throat hospital in the country. In addition to providing patient care, MEE is home to the world’s largest vision and hearing research centers, as well as the Harvard Medical School training programs in ophthalmology (eye) and otolaryngology (ENT.)
The union also marks a culmination of nearly two centuries of collaboration between MEE and Massachusetts General Hospital (MGH). MEE physicians provide leadership and staffing for MGH’s Departments of Ophthalmology and Otolaryngology, and the two hospitals are physically connected on their main campus. Mass. Eye and Ear physicians also lead and staff the Division of Ophthalmology at Brigham and Women’s Hospital (BWH.) In order to provide the best continuity of care for all of these patients, Mass. Eye and Ear has invested in and is now using the Partners Healthcare electronic medical record and patient portal.
“By formally bringing Mass. Eye and Ear into the Partners family we can greatly strengthen the clinical and scientific relationships between our organizations,” said Dr. David Torchiana, President and CEO of Partners HealthCare. “Together we can make Mass. Eye and Ear services and research accessible to a broader population of patients, further improving the quality of life for thousands of individuals and families.”